Impedimed Ltd has released a press release.
Appendix 4C & Quarterly Activities Report
Filed with ASX ·
Watch Impedimed's latest callImpedimed (ASX:IPD) Q1 2027 Earnings Call · Replay · Oct 29Read the transcript of Impedimed (ASX:IPD) Q1 2027 Earnings Call6ix hasn’t read this filing yet.
Earlier from Impedimed
- AstraZeneca extends and increases Renal Contract
- S&P DJI Announces March 2022 Quarterly Rebalance
- ImpediMed Announces End Stage Renal Disease Trial Agreement
- PREVENT Trial Peer-Reviewed and Published
- Share Purchase Plan Successfully Completed
Later from Impedimed
- Lymphoedema Risk Factors Paper Published
- ImpediMed CEO Announces Departure
- Appendix 4C & Quarterly Activities Report - Jun-2022 Qtr
- 2022 Annual Report & Annual General Meeting Date
- New Corporate Oncology Account with GenesisCare
Follow Impedimed into a list and get an email when it puts out news.
Follow Impedimed